Indian pharma stocks plunged sharply following President Trump’s announcement of new drug tariffs. However, analysts urge investors not to panic, highlighting that this sell-off is largely sentiment-driven and the sector’s strong fundamentals remain intact despite the market turbulence
India is overhauling its complex three-tier popcorn tax system in response to the US tariffs imposed during the Trump administration. Officials believe this bold step will streamline duties and spark a surge in domestic manufacturing growth
India has unveiled a bold new strategy to tackle the economic hurdles created by Trump’s 50% tariffs on key exports. This dynamic plan aims to boost trade partnerships and empower domestic industries, fueling long-term growth and resilience
The US 25% tariff on India isn’t just about “making it harder for the Russians,” explains The Economic Times. Rather, this levy reflects broader trade and economic strategies, going beyond simple geopolitical tactics targeting Russia
India and the US have yet to finalize a tariff agreement, prolonging trade tensions that affect key industries on both sides. This ongoing standoff underscores the intricate challenges in their bilateral relationship and threatens to unsettle global economic stability
The US has recently imposed a hefty 50% tariff on Indian goods, all while maintaining zero tariffs for the EU – even as Europe continues to purchase Russian oil. Critics are blasting Washington for blatant hypocrisy amid escalating geopolitical tensions. (NDTV)
As the deadline for President Trump’s tariffs approaches, trade talks between the U.S. and India are intensifying. Both nations aim to address key trade issues, seeking to enhance economic ties while navigating mounting tensions and tariffs.
